Ledger.Open graph →
SEC Form D · filed January 8, 2018

Silverback Therapeutics, Inc

Offering
$4K
Sold
$4K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Robert A. Hershberg · Seattle, WADirectorPeter A. Thompson · Seattle, WAExec · DirectorSaqib A. Islam · Seattle, WADirectorSaqib A. Islam · Seattle, WADirectorRobert A. Hershberg · Seattle, WADirectorPeter A. Thompson · Vancouver, British Columbia, CanadaExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗